adults with the same age and gender distribution who consider themselves overweight but are not using a GLP-1 medication)
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
This helps people feel full faster and for longer
Because of that, patients tend to see dramatic results in a short period of time
Blood Sugar Regulation Changes For patients managing blood sugar or prediabetes, stopping GLP-1 treatment means losing the medication's effect on insulin secretion and glucose regulation
By click-countinglistening to the audible clicks of the injector penpatients could self-administer smaller-than-prescribed amounts
